8 Signs of Ehlers-Danlos Syndrome That Are Easy to Miss

When your body has always been too flexible, it is easy to treat it like a party trick instead of a possible clue. Maybe you could bend your fingers farther than everyone else as a child. Maybe your knees locked backward, your ankles rolled too often, or your shoulders slipped in ways that made people laugh before they became painful. Years later, those same quirks may start showing up as chronic aches, fragile skin, poor balance, digestive problems, fatigue, or joints that feel older than they should.

That is why Ehlers-Danlos syndrome can be so easy to miss. EDS is a group of connective tissue disorders, and connective tissue helps support the skin, joints, blood vessels, and many organs. When that support system is more fragile or stretchy than usual, symptoms can appear all over the body. One person may notice frequent sprains and soft skin. Another may deal with dizziness, jaw pain, bruising, stomach trouble, or pain that seems to move from place to place.

EDS is often described as rare, with a commonly cited estimate of around 1 in 5,000 people, but newer research suggests it may be underdiagnosed. A population study in Wales found diagnosed EDS and hypermobility spectrum disorder together in about 1 in 500 people, showing that these conditions may be more common than many realize.

For many people, the hardest part is not only the symptoms. It is being told for years that they are clumsy, anxious, dramatic, aging too fast, or simply “double-jointed.” That can make the real answer feel both validating and overwhelming. In this article, you will discover 8 signs of Ehlers-Danlos syndrome that are easy to miss. Some may seem small on their own, but together, they can tell a much bigger story about the body’s connective tissue.

8 Hallmarks of Ehlers-Danlos Syndrome

Generalized Joint Hypermobility (GJH)

This is arguably the most well-known feature of EDS, often colloquially referred to as being double-jointed. Clinically, it is defined as the ability of multiple joints to move beyond their normal range of motion. The gold standard for assessing GJH is the Beighton score, a nine-point scale that measures hypermobility in five specific areas: the ability to bend the little finger back past 90 degrees (one point for each hand), the ability to bend the thumb to touch the forearm (one point for each hand), hyperextension of the elbows beyond 10 degrees (one point for each arm), hyperextension of the knees beyond 10 degrees (one point for each leg), and the ability to place the palms flat on the floor with straight knees (one point).

A score of 5 or more in adults, or 6 or more in pre-pubertal children and adolescents, is considered positive for GJH. This joint laxity is not benign; it leads to significant joint instability, resulting in frequent partial dislocations (subluxations) and full dislocations, often from minor trauma or even during daily activities. This chronic instability is a primary driver of acute and chronic pain, joint damage, and early-onset osteoarthritis.

Skin Hyperextensibility

This hallmark refers to the skin’s ability to be stretched beyond its normal limits, after which it recoils back to its original position. In a clinical context, it is assessed by gently pulling the skin, typically on the neutral surface of the forearm where it is not subject to mechanical stress, until resistance is met. The degree of stretch is then measured.

While normal skin stretches minimally, in individuals with certain types of EDS, particularly Classical EDS (cEDS), the skin can be stretched several centimeters (e.g., >1.5 cm is a major criterion for cEDS). It is crucial to distinguish this from the loose, redundant skin seen in other conditions; in EDS, the skin retains its elasticity and snaps back. The texture of the skin is also a key feature; it is often described as exceptionally soft, velvety, or doughy to the touch. This unusual texture and stretchiness are due to the abnormal collagen fiber structure, which fails to provide the dermis with sufficient tensile strength.

Atrophic Scarring

This sign is a direct result of poor wound healing due to tissue fragility. When individuals with EDS sustain even minor injuries, the skin may split easily, creating gaping wounds that heal slowly and poorly. The resulting scars are characteristically atrophic, meaning they are thin, depressed, and often widened. They are frequently described as cigarette paper or papyraceous scars because of their thin, crinkled texture.

These scars may also be hemosiderin-stained, giving them a purplish or brownish discoloration due to the breakdown of red blood cells from underlying minor hemorrhages. Atrophic scarring is most commonly found over pressure points and areas prone to trauma, such as the knees, elbows, shins, and forehead. It serves as a permanent, visible record of the skin’s inherent fragility and is a major diagnostic criterion for Classical EDS.

Tissue Fragility

This is a broader hallmark that encompasses the vulnerability of all connective tissues throughout the body, not just the skin and joints. It manifests in various ways, including easy bruising, where individuals develop significant bruises from minimal trauma or sometimes for no apparent reason. This is attributed to the fragility of capillaries and the supporting connective tissue surrounding them. Other manifestations include the development of hernias (inguinal, umbilical, hiatal, or incisional) due to weakness in the abdominal wall, pelvic floor prolapse, and rectal prolapse.

In a surgical context, tissues may be friable, meaning they tear easily and do not hold sutures well, leading to complications like wound dehiscence (reopening). In its most extreme and life-threatening form, seen in Vascular EDS (vEDS), this fragility extends to arteries, the intestines, and the uterus, placing individuals at high risk for spontaneous rupture and catastrophic internal bleeding.

Chronic Widespread Pain

This is one of the most pervasive and disabling symptoms of EDS, particularly in the hypermobile type (hEDS). The pain is complex and multifactorial. It stems from several sources: acute pain from frequent joint dislocations and subluxations; chronic musculoskeletal pain from joint instability, which forces muscles to work constantly to stabilize the skeleton, leading to fatigue, spasms, and myofascial pain; early-onset osteoarthritis from cumulative joint damage; and neuropathic pain resulting from nerve compression or entrapment by unstable joints or other structures.

Furthermore, many individuals with EDS develop central sensitization, a condition where the central nervous system becomes amplified and hypersensitive to pain signals, causing them to experience pain from stimuli that would not normally be painful (allodynia) or to experience pain more intensely than expected (hyperalgesia). This chronic pain is often widespread, affecting multiple body parts, and can be resistant to standard pain management strategies.

Musculoskeletal Complications

Beyond the immediate consequences of joint instability, the long-term strain of faulty connective tissue leads to a variety of structural musculoskeletal issues. These complications develop over time due to the body’s inability to maintain proper form and function against the forces of gravity and movement.

Common examples include scoliosis (sideways curvature of the spine) or kyphosis (forward rounding of the upper back), which can be progressive and painful. Pes planus, or flat feet, is extremely common due to the collapse of the arches. Temporomandibular joint (TMJ) dysfunction is also prevalent, causing jaw pain, clicking, and locking. Individuals with EDS are also prone to developing hernias and may experience recurrent tendonitis or bursitis because the tendons and ligaments are more susceptible to strain and injury.

Associated Comorbidities

Ehlers-Danlos Syndrome is strongly associated with a number of other conditions, which are now understood to be related to the same underlying connective tissue and autonomic nervous system dysfunction. The recognition of these comorbidities is a key part of the modern understanding of EDS.

Postural Orthostatic Tachycardia Syndrome (POTS) is a disorder of the autonomic nervous system characterized by an abnormal increase in heart rate upon standing, leading to symptoms like lightheadedness, fainting, palpitations, and fatigue. It is thought to be linked to laxity in the blood vessels.

Also, Mast Cell Activation Syndrome (MCAS) is a condition where mast cells (a type of immune cell) become overactive and release excessive amounts of chemical mediators, causing a wide range of allergic-type symptoms. These can include hives, flushing, itching, gastrointestinal distress, respiratory issues, and even anaphylaxis.

Many individuals with EDS experience significant GI problems due to laxity in the connective tissue of the digestive tract. This can manifest as gastroparesis (delayed stomach emptying), acid reflux, irritable bowel syndrome (IBS), chronic constipation, and food intolerances. Other associated issues can include anxiety disorders, pelvic floor dysfunction, and sleep disturbances like sleep apnea.

Positive Family History

As a group of heritable disorders, genetics play a central role in EDS. The majority of EDS subtypes, including Hypermobile and Classical EDS, are inherited in an autosomal dominant pattern. This means that an individual with the condition has a 50% chance of passing the responsible gene to each of their children. Therefore, a key component of the diagnostic process is taking a detailed family medical history.

Clinicians will look for evidence of the same hallmarks. hypermobility, skin issues, chronic pain, and related comorbidities, in parents, siblings, and other relatives. While a positive family history provides strong evidence, its absence does not rule out EDS. A spontaneous mutation (de novo mutation) can occur, meaning an individual can be the first person in their family to have the condition.

What is Ehlers-Danlos Syndrome Fundamentally?

Ehlers-Danlos Syndrome (EDS) is fundamentally a group of 13 distinct, heritable disorders of connective tissue caused by genetic defects that affect the structure, synthesis, or processing of collagen and related proteins. Collagen is the most abundant protein in the human body, acting as the primary structural component of skin, bones, ligaments, tendons, blood vessels, and internal organs. It functions as the body’s glue, providing strength, elasticity, and integrity to these tissues.

In individuals with EDS, genetic mutations disrupt this crucial protein, leading to connective tissue that is inherently weak and fragile. This fundamental defect is why the symptoms of EDS are so widespread, affecting nearly every body system. The specific gene mutation determines which of the 13 subtypes an individual has, each with its own unique set of clinical features and diagnostic criteria.

For example, Classical EDS (cEDS) is typically caused by mutations in genes responsible for type V collagen, leading to profound skin hyperextensibility and atrophic scarring. The most life-threatening type, Vascular EDS (vEDS), is caused by defects in type III collagen, which is critical for the integrity of blood vessels and hollow organs. The most common type, Hypermobile EDS (hEDS), is unique in that its underlying genetic cause remains unknown, making its diagnosis entirely clinical.

More specifically, this shared pathology explains the spectrum of disease severity and presentation. The universal issue across all EDS types is compromised connective tissue. This tissue’s functions include providing structural support (like the framework of organs), enabling elasticity (allowing skin and vessels to stretch and recoil), and facilitating wound healing. When this tissue is faulty, none of these functions can be performed properly.

Each of the 12 subtypes with a known genetic cause is linked to mutations in specific genes. These genes provide the instructions for making different types of collagen or the enzymes that help process and assemble collagen molecules. A flaw in these instructions leads to the production of abnormal, dysfunctional collagen.

The 2017 International Classification for the Ehlers-Danlos Syndromes officially defined the 13 subtypes based on their distinct genetic causes and clinical presentations. This system created standardized diagnostic criteria for each type, which has been crucial for improving diagnostic accuracy and guiding research. The main types include Hypermobile (hEDS), Classical (cEDS), Vascular (vEDS), Classical-like (clEDS), Cardiac-valvular (cvEDS), Arthrochalasia (aEDS), Dermatosparaxis (dEDS), Kyphoscoliotic (kEDS), Brittle Cornea Syndrome (BCS), Spondylodysplastic (spEDS), Musculocontractural (mcEDS), Myopathic (mEDS), and Periodontal (pEDS).

The Diagnostic Process for EDS

The diagnostic process for Ehlers-Danlos Syndrome is primarily clinical, involving a comprehensive physical examination to assess the hallmarks, a detailed personal and family medical history, and the strict application of specific diagnostic criteria for each subtype, which is then supplemented by genetic testing for confirmation in 12 of the 13 types. The process is often led by a geneticist or a rheumatologist with expertise in heritable connective tissue disorders. It is not a simple diagnosis based on a single blood test but rather a careful and systematic piecing together of clinical evidence.

The journey begins with recognizing the pattern of signs and symptoms, the hallmarks, which then triggers a more formal evaluation. This evaluation aims to identify which specific subtype of EDS a person has, or if their symptoms might be indicative of a different connective tissue disorder altogether, necessitating a differential diagnosis to rule out conditions like Marfan syndrome, Loeys-Dietz syndrome, or other hypermobility spectrum disorders.

Step 1: Clinical History and Physical Examination:

This is the foundational step. The physician will take a detailed medical history, asking about chronic pain, dislocations, wound healing, bruising, and any associated comorbidities like POTS or GI issues. A family history is crucial to identify potential inheritance patterns. The physical exam is hands-on and focuses on quantifying the hallmarks. This includes performing the Beighton score to measure generalized joint hypermobility, assessing skin stretchiness and texture, and looking for characteristic atrophic scars. The clinician will also check for other physical signs like flat feet, scoliosis, or a high-arched palate.

Step 2: Application of Diagnostic Criteria:

For each of the 13 subtypes of EDS, there is a specific set of diagnostic criteria established by the 2017 international consortium. The clinician uses the findings from the history and physical exam to see if the patient meets the criteria for a specific type. For example, to diagnose Hypermobile EDS (hEDS), a patient must meet all three of the following criteria:

Criterion 1: A positive Beighton score confirming generalized joint hypermobility.

Criterion 2: The presence of a certain number of other features, which are broken down into categories reflecting systemic manifestations of a more widespread connective tissue disorder (e.g., skin signs, widespread pain, positive family history).

Criterion 3: The exclusion of other possible diagnoses. This means all other heritable and acquired connective tissue disorders, as well as autoimmune rheumatic diseases, must be ruled out.

Step 3: Genetic Testing:

For the 12 types of EDS with a known genetic basis, molecular testing is the final step to confirm the diagnosis. A blood sample is taken, and DNA is analyzed to look for mutations in the suspected gene(s). This is particularly critical for Vascular EDS (vEDS) due to the serious risk of arterial or organ rupture, as a confirmed diagnosis allows for proactive surveillance and management.

Genetic testing is also essential for accurate genetic counseling, allowing individuals and families to understand inheritance risks. For hEDS, because the genetic cause is not yet known, diagnosis remains purely clinical, and genetic testing is primarily used to rule out other EDS subtypes that may present similarly.

Ehlers-Danlos Syndrome and Other Related Conditions

Ehlers-Danlos Syndrome is managed through a supportive, multidisciplinary approach focusing on symptom relief and is differentiated from similar conditions by its unique combination of clinical features and, in some cases, specific genetic markers. Effectively navigating life with EDS requires a deep understanding not only of its primary hallmarks but also of its complex web of associated conditions, tailored management strategies, and its distinction from other heritable connective tissue disorders.

Furthermore, this knowledge empowers individuals to build a team of healthcare providers who can collaboratively address the multifaceted challenges of the syndrome, from physical therapy to pain management and mental health support. Addressing these elements is fundamental to improving daily function and overall quality of life.

Common Comorbidities Associated With EDS

Beyond the direct manifestations of faulty collagen, individuals with Ehlers-Danlos Syndrome frequently experience a cluster of related conditions, or comorbidities, that significantly impact their health and daily functioning. The underlying laxity of connective tissue and associated systemic dysfunction create a predisposition for these secondary diagnoses.

One of the most common is Postural Orthostatic Tachycardia Syndrome (POTS), a form of dysautonomia where the autonomic nervous system fails to regulate blood pressure and heart rate correctly. Upon standing, blood pools in the lower extremities, causing a rapid increase in heart rate, dizziness, fainting, and profound fatigue.

Another prevalent comorbidity is Mast Cell Activation Syndrome (MCAS), where mast cells, a type of immune cell, inappropriately release chemical mediators, leading to a wide range of allergic-like symptoms such as hives, flushing, gastrointestinal distress, and even anaphylaxis. The connection is thought to involve the chronic inflammation and structural instability inherent in EDS. These three conditions – EDS, POTS, and MCAS – are often referred to as a “trifecta,” as they so frequently occur together.

Understanding these associated conditions is crucial for comprehensive EDS management, as their symptoms can be as disabling as the primary joint and skin issues. Craniocervical Instability (CCI) occurs when the ligaments in the upper cervical spine are too lax to adequately support the skull on the neck. This instability can lead to compression of the brainstem and spinal cord, causing severe headaches, brain fog, vision disturbances, balance problems, and other neurological symptoms.

In addition, the connective tissue that forms the digestive tract can be weak and stretchy, leading to a host of problems. These include gastroparesis (delayed stomach emptying), acid reflux, and symptoms mirroring Irritable Bowel Syndrome (IBS), such as bloating, pain, constipation, and diarrhea, all stemming from impaired gut motility and integrity.

While considered symptoms, the severity and persistence of pain and fatigue in EDS often rise to the level of a comorbid diagnosis like fibromyalgia or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This pain is often neuropathic (nerve-related) and nociceptive (tissue-damage-related) and is exacerbated by joint instability and micro-traumas.

Ehlers-Danlos Syndrome and Other Connective Tissue Disorders

While Ehlers-Danlos Syndrome is part of a larger family of heritable connective tissue disorders, it has distinct clinical and genetic features that differentiate it from similar conditions like Marfan Syndrome, Loeys-Dietz Syndrome, and Hypermobility Spectrum Disorder. Distinguishing between them is critical for accurate prognosis and management, especially regarding cardiovascular risks.

Marfan Syndrome, for example, is caused by mutations in the FBN1 gene, affecting fibrillin-1 protein. Although it shares joint hypermobility with EDS, its hallmark features are a tall, slender build with disproportionately long limbs (arachnodactyly), significant eye problems such as dislocation of the lens (ectopia lentis), and, most critically, a high risk of life-threatening aortic root aneurysm and dissection. These specific features are central to its diagnosis and less prominent or expressed differently in most EDS types.

Another condition, Loeys-Dietz Syndrome (LDS), is an aggressive arteriopathy caused by mutations in genes like TGFBR1 and TGFBR2. While it can present with skin laxity and joint hypermobility similar to EDS, LDS is defined by widespread and rapidly progressing arterial aneurysms throughout the body and distinctive craniofacial features like widely spaced eyes (hypertelorism) or a split uvula.

The most challenging distinction lies with Hypermobility Spectrum Disorder (HSD), which occupies the same clinical space as the hypermobile type of EDS (hEDS). Hypermobility Spectrum Disorder (HSD) is diagnosed in patients who have symptomatic joint hypermobility but do not meet the full, strict diagnostic criteria for hEDS or any other connective tissue disorder.

The symptoms including pain, instability, fatigue can be just as severe as in hEDS. The distinction is a matter of classification; hEDS requires a specific combination of generalized joint hypermobility, systemic signs of a connective tissue disorder (e.g., specific skin features, pelvic floor prolapse), and a family history. HSD is a diagnosis for those who fall short of this specific constellation of findings.

The 2017 diagnostic criteria for hEDS were made intentionally strict to facilitate genetic research. This means a patient with HSD and a patient with hEDS may have a very similar clinical presentation and require identical management, but only the hEDS patient meets the research-level diagnostic checklist.

While the genetic causes for many EDS types are known (e.g., COL5A1/COL5A2 for classical EDS), the gene(s) for hEDS have not yet been identified. This makes the clinical diagnosis paramount for hEDS, whereas conditions like Marfan and Loeys-Dietz have confirmed genetic tests that can finalize the diagnosis.

Management Strategies to Help with EDS Symptoms

Since there is no cure for Ehlers-Danlos Syndrome, management focuses on a proactive, multipronged approach to minimize symptoms, prevent injury, and improve quality of life. Treatment is highly individualized and requires a team of specialists who understand the unique challenges of the condition. Physical therapy is a cornerstone of management, but it must be tailored specifically for hypermobility.

Standard physical therapy that pushes for deep stretching or aggressive strengthening can cause dislocations and further injury. Specialized programs, such as the Muldowney Protocol, emphasize very slow, controlled strengthening of the small, deep stabilizing muscles that support the joints, alongside extensive proprioceptive training to improve joint position sense. This helps create muscular armor to compensate for lax ligaments.

Pain management is another critical component, often requiring a multimodal strategy that avoids over-reliance on opioids. This can include medications like low-dose naltrexone for central sensitization, topical analgesics, nerve blocks, and non-pharmacological interventions like Transcutaneous Electrical Nerve Stimulation (TENS) units, gentle heat or cold therapy, and mindfulness practices.

Effective daily management also involves integrating lifestyle adjustments and supportive aids to protect the body. Using aids is not a sign of weakness but a smart strategy for joint protection and energy conservation. This can range from ring splints to prevent finger hyperextension, custom orthotics for foot support, and compression garments to improve proprioception and manage POTS symptoms. For more significant instability, soft or rigid braces for knees, ankles, and wrists may be necessary, while canes, crutches, or wheelchairs can prevent falls and manage severe fatigue.

Besides, pacing is a fundamental skill for managing the fluctuating energy levels common in EDS. This involves breaking tasks into smaller chunks and balancing activity with rest to avoid the push-crash cycle. Ergonomic adjustments at home and work, such as supportive chairs and modified workstations, reduce daily strain on vulnerable joints.

A nutrient-dense, anti-inflammatory diet can help manage gastrointestinal symptoms and systemic inflammation. Equally important is psychological support from a therapist familiar with chronic illness to develop coping strategies for pain, physical limitations, and the emotional burden of living with an often-invisible condition.

Is it Possible to Live a Full Life with Ehlers-Danlos Syndrome?

Absolutely, it is possible to live a full and meaningful life with Ehlers-Danlos Syndrome, although it often requires a significant redefinition of what full means. Living well with a chronic, multisystemic condition like EDS is less about curing the illness and more about mastering the art of adaptation, proactive management, and self-advocacy.

The journey involves accepting a new normal where physical limitations must be respected, but capabilities are celebrated and maximized. This mindset shift is foundational, moving the focus from what has been lost to what can be achieved within the body’s new set of rules.

Success hinges on developing robust adaptive strategies. This includes diligent pacing to manage energy and pain, often visualized with concepts like the spoon theory using mobility aids without shame to enable participation in life, and modifying home, work, and social activities to be more accessible and less physically taxing. Breaking down goals into smaller, more manageable steps can prevent the overwhelming boom-and-bust cycle that is common with chronic illness.

A cornerstone of a successful life with EDS is building and coordinating a dedicated, knowledgeable multidisciplinary care team. No single doctor can manage all aspects of EDS. An ideal team may include a primary care physician who acts as a central coordinator, a rheumatologist or geneticist for diagnosis, a physical therapist specializing in hypermobility, a pain management specialist, a cardiologist to monitor for associated vascular issues, a gastroenterologist, and a mental health professional. Coordinated care ensures that all body systems are monitored and that treatments do not conflict.

The invisible nature of EDS can be incredibly isolating. Connecting with others who understand the daily struggles is vital for mental and emotional well-being. Online forums, social media groups, and local support organizations provide a space for validation, sharing practical tips, and feeling understood. This sense of community combats the loneliness that often accompanies chronic illness.

Specially, the most empowered patients are the most educated. Learning as much as possible about the condition, its comorbidities, and management options allows individuals to become active partners in their healthcare. This enables them to advocate for themselves effectively in medical settings, ask informed questions, and make decisions that align with their personal goals for quality of life.

FAQs

1. What is the life expectancy of someone with Ehlers-Danlos Syndrome?

Life expectancy depends on the type of Ehlers-Danlos syndrome. Many people with the more common hypermobile type can live a typical lifespan, although daily life may be affected by pain, fatigue, joint instability, dizziness, digestive issues, or injuries. The condition may not shorten life, but it can still change how a person moves, works, sleeps, and plans their day.

Some rare types can be more serious. Vascular EDS, for example, can affect blood vessels and internal organs, which may increase the risk of life-threatening complications. That is why getting the correct EDS type diagnosed matters so much.

2. How does Ehlers-Danlos make you feel?

EDS can make the body feel unpredictable. One day may feel manageable, then the next may bring aching joints, loose ankles, shoulder pain, fatigue, dizziness, or skin that bruises from small bumps. Some people describe feeling like their body is working harder than everyone else’s just to stay upright and stable.

It can also feel emotionally draining. Being told “you look fine” while dealing with pain, injuries, stomach problems, sleep trouble, or brain fog can make people feel dismissed. EDS affects connective tissue, and connective tissue is found throughout the body, so symptoms can show up in many places at once. The Ehlers-Danlos Society describes EDS as a group of 13 heritable connective tissue disorders, often involving joint hypermobility, skin stretchiness, and tissue fragility.

3. Is Ehlers-Danlos Syndrome a form of autism?

No, EDS is not a form of autism. EDS is a connective tissue disorder, while autism is a neurodevelopmental condition. They are different diagnoses with different causes and features.

However, research has explored possible overlap between joint hypermobility, EDS, and autism. Some autistic people also have hypermobility or EDS, and some people with EDS may have autistic traits or related sensory sensitivities. That does not mean one condition is the same as the other. It means some people may experience both and need care that understands the full picture.

4. At what age does Ehlers-Danlos Syndrome usually start?

EDS is genetic, so a person is born with it. However, symptoms may not be recognized right away. Some children show signs early, such as unusual flexibility, frequent sprains, clumsiness, soft skin, easy bruising, delayed motor skills, or joint pain after activity.

Others do not connect the dots until adolescence or adulthood. Hormonal changes, injuries, pregnancy, illness, repetitive strain, or aging can make symptoms more noticeable. Many adults look back and realize the signs were there for years, but they were called growing pains, awkwardness, anxiety, or being “double-jointed.”

5. What are the facial signs of EDS?

Facial signs depend on the EDS type. Many people with hypermobile EDS may not have obvious facial features. Some rare types, especially vascular EDS, may be associated with features such as thin lips, a narrow nose, prominent eyes, small chin, thin skin, or visible veins. These signs alone cannot diagnose EDS.

It is also possible for someone with EDS to look completely typical. That can make the condition harder to recognize. Doctors usually look at the whole pattern: joint flexibility, skin features, bruising, scars, dislocations, family history, pain, and other body-wide symptoms.

6. Do people with EDS have low magnesium?

Some people with EDS may have low magnesium, but low magnesium is not considered a defining feature of EDS. Muscle cramps, twitching, fatigue, headaches, and poor sleep can make people wonder about magnesium, but those symptoms can also come from pain, poor sleep, dysautonomia, stress, medications, diet, or other health conditions.

Supplements should be used carefully. Too much magnesium can cause diarrhea, weakness, low blood pressure, or more serious problems in people with kidney issues. Anyone considering magnesium for cramps, sleep, or pain should check the dose and discuss it with a healthcare provider, especially if they already take medications.

7. What are the mental health issues with Ehlers-Danlos Syndrome?

People with EDS may experience anxiety, depression, medical trauma, frustration, grief, or fear of injury. These mental health struggles are not “all in the head.” They often come from living with chronic pain, repeated dislocations, fatigue, sleep problems, dismissed symptoms, and the stress of not knowing what is wrong for years.

Dysautonomia, sensory sensitivity, and constant body monitoring can also make anxiety feel worse. Supportive therapy, pain management, pacing, physical therapy, and validation can help. A person with EDS needs care that respects both physical symptoms and emotional strain.

8. Do people with EDS sleep a lot?

Some people with EDS sleep more than others because the body is dealing with pain, fatigue, poor recovery, autonomic symptoms, or exhausting daily movement. Others sleep for many hours but still wake up tired because pain, joint instability, reflux, restless legs, or breathing issues interrupt deep rest.

Fatigue can be one of the most frustrating parts of EDS. It may feel like the body spends extra energy holding joints together, avoiding injury, and managing discomfort. If someone with EDS suddenly needs much more sleep than usual, it is worth checking for anemia, thyroid issues, sleep apnea, medication effects, vitamin deficiencies, or other causes.

9. What are the uncommon symptoms of Ehlers-Danlos Syndrome?

Uncommon or less recognized EDS symptoms can include jaw problems, dental crowding, gum issues, dizziness when standing, heart palpitations, digestive slowdowns, reflux, pelvic floor problems, bladder issues, headaches, nerve pain, poor wound healing, unusual scarring, easy bruising, and sensitivity to local anesthetics.

Some people also report temperature regulation problems, frequent subluxations, rib slipping, coat-hanger pain in the neck and shoulders, or feeling unsteady in space. EDS can look different from one person to another, which is why a full symptom pattern matters more than one single sign.

10. Does Ehlers-Danlos make you look older or younger?

EDS can affect appearance in different ways. Some people have soft, smooth, stretchy skin that may make them appear younger. Others may develop thin or fragile skin, visible veins, easy bruising, scars, or skin that feels delicate. The effect depends on the EDS type, skin quality, sun exposure, age, genetics, and overall health.

It is not accurate to say EDS always makes someone look younger or older. Some people notice fewer wrinkles, while others deal with skin fragility or scarring that makes them feel self-conscious. The visible signs vary widely.

11. Why do people with Ehlers-Danlos Syndrome not get wrinkles?

Some people with EDS may appear to have smoother skin because their connective tissue behaves differently. Stretchy or unusually soft skin can sometimes create a youthful look, and this has led to the idea that people with EDS do not get wrinkles.

But that is not true for everyone. People with EDS can still get wrinkles, especially with age, sun exposure, smoking, dehydration, and normal skin changes. Some types of EDS involve fragile or thin skin, which may create different concerns, such as bruising, tearing, or poor scar healing. Smooth skin can be one clue, but it is not a rule.

Conclusion

Ehlers-Danlos syndrome is easy to miss because its signs can look like separate problems: flexible joints, soft skin, frequent sprains, fatigue, dizziness, bruising, stomach issues, or pain that moves around the body. For many people, the hardest part is spending years being told those symptoms are normal, exaggerated, or unrelated.

EDS is not just being double-jointed. It is a connective tissue condition that can affect the skin, joints, blood vessels, digestion, sleep, balance, and daily comfort. The symptoms may be subtle at first, but the pattern can tell an important story. If your body has always felt fragile, overly flexible, painful, or unpredictable, it may be worth asking deeper questions. Recognition can bring relief, better care, safer movement, and the feeling that your experience finally makes sense.

References

• NHS – Ehlers-Danlos syndromes
• The Ehlers Danlos Society – What is EDS?
• Boston Children’s Hospital – What is Ehlers-Danlos syndrome (EDS)?
• The University of Texas Southwestern Medical Center – Ehlers-Danlos syndrome: Diagnosing and treating an ‘invisible’ disease
• Weill Cornell Medicine – Symptoms and Signs of Ehlers-Danlos Syndrome
• Global Genes – About Ehlers-Danlos Syndrome
• National Library of Medicine – Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons
• Arthritis Foundation – Ehlers-Danlos Syndrome
• Rare Voices Australia – Ehlers-Danlos Syndromes (EDS) (Group of conditions)
• Cedars-Sinai – Ehlers-Danlos Syndrome
• The Marfan Foundation – Ehlers-Danlos Syndrome
• Healthdirect Australia Limited – Ehlers-Danlos syndrome